Skip to main content
The Pennant Group, Inc. (PNTG)
NASDAQ: PNTG · IEX Real-Time Price · USD
21.20
-0.06 (-0.28%)
At close: May 2, 2024, 4:00 PM
21.45
+0.25 (1.18%)
After-hours: May 2, 2024, 5:57 PM EDT

The Pennant Group Revenue

In the year 2023, The Pennant Group had annual revenue of $544.89M with 15.14% growth. Revenue in the quarter ending December 31, 2023 was $145.95M with 17.08% year-over-year growth.

Revenue (ttm)
$544.89M
Revenue Growth
+15.14%
P/S Ratio
1.17
Revenue / Employee
$94,093
Employees
5,791
Market Cap
636.27M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023544.89M71.65M15.14%
Dec 31, 2022473.24M33.55M7.63%
Dec 31, 2021439.69M48.74M12.47%
Dec 31, 2020390.95M52.42M15.49%
Dec 31, 2019338.53M52.47M18.34%
Dec 31, 2018286.06M35.07M13.97%
Dec 31, 2017250.99M33.77M15.54%
Dec 31, 2016217.23M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fulgent Genetics 289.21M
Castle Biosciences 219.79M
Quanterix 122.37M
Zymeworks 76.01M
CureVac 59.73M
Exscientia 25.42M
Lyell Immunopharma 130.00K
Revenue Rankings

PNTG News

More News